What is CLDI's dilution risk score?

CLDI has a latest available DilutionScore record of 72/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CLDI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CLDI?

DilutionWatch tracks 25 SEC filing types for CLDI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CLDI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CLDI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CLDI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CLDI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CLDI Dilution Risk Score: 72/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

65

📊 Float Risk

20

⚠️ Warrant Exposure

90

🔄 Convertible Debt

85

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 62%

🔄 Reverse Split model est. 65%

• 50-day avg $0.23 below $1 exchange minimum

• 8 months cash with weak price

📜 Warrant Exercise model 60%

• Massive warrant overhang: 101% of shares outstanding

• Warrant risk score very high (90/100)

🔁 Convertible Conversion model 60%

• Major convertible overhang: 50% potential dilution

• Convertible risk score very high (85/100)

🔔 Track CLDI — Get forecast alerts →

Market Data

Market Cap$3.57M

Shares Outstanding19.31M

Float10.72M

Cash$9.60M

Debt$645.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 354.2% shares (2026Q1 vs prior)

29 institutional holders · 2.04M shares

#1 ARMISTICE CAPITAL, LLC 879.0K shares

#2 SABBY MANAGEMENT, LLC 434.9K shares

#3 Warberg Asset Management LLC 250.0K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest231.3K

Days to Cover1.0

% of Float2.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2024-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CLDI Dilution Snapshot

Calidi Biotherapeutics, Inc. (CLDI) has a DilutionScore of 72/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 2.6M.
Recent SEC activity tracked for CLDI: xbrl on 2026-06-30; xbrl on 2024-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.